Wegovy , developed by Novo Nordisk , is a breakthrough medication that contains semaglutide , a GLP-1 receptor agonist originally used in diabetes management
This is why many women feel like they are doing everything right, eating carefully and exercising, yet the scale will not move
Should you experience any persistent or bothersome side effects, discuss them with your healthcare provider for appropriate management
Sermorelin stimulates growth hormone production, helping to boost metabolism and preserve lean muscle mass
These hormones promote feelings of fullness after eating, insulin secretion and production, and help reduce hunger to avoid overeating
Share your interest in GLP-1 medications and discuss how the combination will be managed